Overview
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic is advancing preclinical programs in autoimmunity, fibrosis, vascular disorders and immuno-oncology.